Increased Tumor-Specific CD8+ T Cell Induction by Dendritic Cells Matured with a Clinical Grade TLR-Agonist in Combination with IFN-γ

IFN-  Arms Human Dendritic Cells to Perform Multiple Effector Functions

(2014) L. Frasca et al.   JOURNAL OF IMMUNOLOGY

Cell Death Mechanisms Induced by Cytotoxic Lymphocytes

(2010) L Chávez-Galán et al.   Cellular & Molecular Immunology

Harnessing Dendritic Cells to Generate Cancer Vaccines

(2009) Karolina Palucka et al.   Annals of the New York Academy of Sciences

Variation matters: TLR structure and species-specific pathogen recognition

(2009) Dirk Werling et al.   TRENDS IN IMMUNOLOGY

Tumor-specific Th17-polarized cells eradicate large established melanoma

(2008) P. Muranski et al.   BLOOD

Enhancement of CD4+ T-cell help reverses the doxorubicin-induced suppression of antigen-specific immune responses in vaccinated mice

(2008) D Kim et al.   GENE THERAPY

In Vivo Tracking of Dendritic Cells in Patients With Multiple Myeloma

(2008) H. Miles Prince et al.   JOURNAL OF IMMUNOTHERAPY

TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function

(2008) Liang Zhou et al.   NATURE

The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine

(2008) C. Trumpfheller et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: Implications for vaccines

(2008) Q. Zhu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA